Central Diagnostic Laboratory-Research, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Paediatric Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Br J Haematol. 2021 Jun;193(6):1185-1193. doi: 10.1111/bjh.17524. Epub 2021 May 17.
The diagnostic evaluation of Diamond Blackfan Anaemia (DBA), an inherited bone marrow failure syndrome characterised by erythroid hypoplasia, is challenging because of a broad phenotypic variability and the lack of functional screening tests. In this study, we explored the potential of untargeted metabolomics to diagnose DBA. In dried blood spot samples from 18 DBA patients and 40 healthy controls, a total of 1752 unique metabolite features were identified. This metabolic fingerprint was incorporated into a machine-learning algorithm, and a binary classification model was constructed using a training set. The model showed high performance characteristics (average accuracy 91·9%), and correct prediction of class was observed for all controls (n = 12) and all but one patient (n = 4/5) from the validation or 'test' set (accuracy 94%). Importantly, in patients with congenital dyserythropoietic anaemia (CDA) - an erythroid disorder with overlapping features - we observed a distinct metabolic profile, indicating the disease specificity of the DBA fingerprint and underlining its diagnostic potential. Furthermore, when exploring phenotypic heterogeneity, DBA treatment subgroups yielded discrete differences in metabolic profiles, which could hold future potential in understanding therapy responses. Our data demonstrate that untargeted metabolomics in dried blood spots is a promising new diagnostic tool for DBA.
Diamond Blackfan 贫血(DBA)是一种遗传性骨髓衰竭综合征,其特征为红系发育不良,其诊断评估具有挑战性,原因是表型变异广泛,且缺乏功能筛选试验。在这项研究中,我们探索了非靶向代谢组学诊断 DBA 的潜力。在 18 名 DBA 患者和 40 名健康对照的干血斑样本中,共鉴定出 1752 种独特的代谢物特征。该代谢指纹被纳入机器学习算法,并使用训练集构建了二分类模型。该模型表现出较高的性能特征(平均准确率为 91.9%),且在验证集或“测试”集中,所有对照(n=12)和除 1 名患者(n=4/5)外,所有患者均得到正确预测(准确率为 94%)。重要的是,在具有重叠特征的先天性红细胞生成不良性贫血(CDA)患者中,我们观察到了明显不同的代谢谱,这表明 DBA 特征指纹具有疾病特异性,并强调了其诊断潜力。此外,在探索表型异质性时,DBA 治疗亚组的代谢谱存在明显差异,这可能在未来有助于理解治疗反应。我们的数据表明,干血斑的非靶向代谢组学是一种很有前途的 DBA 新诊断工具。